Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan最新文献

筛选
英文 中文
Exploring the role of Yishen Qufeng formula in alleviating renal injury in diabetic kidney disease ratsregulating pyroptosis through the nucleotide-binding oligomerization domain-like receptor protein 3/caspase-1/gasdermin D pathway. 探讨益肾祛风方通过核苷酸结合寡聚化结构域样受体蛋白3/caspase-1/gasdermin D通路调控焦亡的作用
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan Pub Date : 2026-10-01 DOI: 10.19852/j.cnki.jtcm.2026.05.010
Zhao Xueshan, Chen Ansheng, Yong Chen, Huang Guoshun, Zhou Enchao
{"title":"Exploring the role of Yishen Qufeng formula in alleviating renal injury in diabetic kidney disease ratsregulating pyroptosis through the nucleotide-binding oligomerization domain-like receptor protein 3/caspase-1/gasdermin D pathway.","authors":"Zhao Xueshan, Chen Ansheng, Yong Chen, Huang Guoshun, Zhou Enchao","doi":"10.19852/j.cnki.jtcm.2026.05.010","DOIUrl":"https://doi.org/10.19852/j.cnki.jtcm.2026.05.010","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the mechanism and target sites of Yishen Qufeng formula (, YSQF) in alleviating renal injury caused by diabetic kidney disease (DKD), with a focus on the nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3)/ caspase-1/gasdermin D (GSDMD) signaling pathway.</p><p><strong>Methods: </strong>A DKD rat model was established using unilateral nephrectomy combined with intraperitoneal injection of streptozotocin. Rats were randomly assigned to four groups: control, model, irbesartan (IRB), and YSQF. The IRB group received oral IRB, and the YSQF group received oral YSQF decoction, while the control and model groups received an equal volume of normal saline. After 12 weeks of intervention, we detected hepatic and renal function-related indicators, such as serum creatinine, alanine aminotransferase (ALT), and 24-h urinary total protein (24-h UTP), as well as serum inflammatory cytokines interleukin (IL)-1β. In addition, histopathological evaluation, including hematoxylin and eosin staining, Masson's trichrome staining, and terminal deoxynucleotidyl transferase dUTP nick end labeling staining, was performed. The mRNA expression of pyroptosis-related markers in renal tissue was assessed by quantitative real-time reverse transcription polymerase chain reaction, and the corresponding protein expression was assessed by Western blotting.</p><p><strong>Results: </strong>Compared with the control group, the model group showed significantly increased 24-h UTP and albumin-to-creatinine ratio, as well as elevated serum levels of IL-1β and IL-18. These biochemical alterations were accompanied by more severe renal histopathological damage, increased renal fibrosis, enhanced renal cell apoptosis, and increased NLRP3 immunohistochemical staining intensity. In addition, the mRNA expression levels of NLRP3 and apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) were significantly upregulated. The protein levels of NLRP3, ASC, cleaved-caspase-1, and the N-terminal fragment of gasdermin D (GSDMD-N) were also significantly increased. In contrast, compared with the model group, the YSQF group demonstrated significant amelioration, including lower 24-h UTP levels. Serum concentrations of IL-1β and IL-18 were also significantly decreased. These changes were accompanied by amelioration of renal histopathological injury, reduced fibrosis and apoptosis, decreased NLRP3 immunohistochemical staining, decreased mRNA expression of NLRP3 and ASC in renal tissue, and reduced protein levels of NLRP3, cleaved-caspase-1, and GSDMD-N.</p><p><strong>Conclusion: </strong>YSQF formula alleviates renal injury in DKD rats by suppressing renal cell pyroptosis <i>via</i>downregulation of the NLRP3/caspase-1/GSDMD signaling pathway, thereby mitigating inflammatory responses, improving renal pathology, and attenuating renal fibrosis.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"46 5","pages":"1160-1171"},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684368/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149303433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrative network pharmacology and experimental validation to decipher the anti-angiogenic mechanisms of Xuandan Sanjie decotion in adenomyosis. 宣丹散结汤抗bb0血管生成机制的综合网络药理学及实验验证。
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan Pub Date : 2026-10-01 DOI: 10.19852/j.cnki.jtcm.20260514.001
Gan Lin, Zhou Fangfang, Qiu Yingying, Huang Meihua, L I Zhenli, Gui Tao
{"title":"Integrative network pharmacology and experimental validation to decipher the anti-angiogenic mechanisms of Xuandan Sanjie decotion in adenomyosis.","authors":"Gan Lin, Zhou Fangfang, Qiu Yingying, Huang Meihua, L I Zhenli, Gui Tao","doi":"10.19852/j.cnki.jtcm.20260514.001","DOIUrl":"https://doi.org/10.19852/j.cnki.jtcm.20260514.001","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the mechanisms by which Xuandan Sanjie decoction (, XSD) inhibits angiogenesis in adenomyosis (AM), using both AM-derived primary endometrial stromal cells (ESCs) and a mouse model.</p><p><strong>Methods: </strong>Core components and targets of XSD for AM treatment were predicted using multiple databases. Gene ontology and kyoto encyclopedia of genes and genomes pathway analyses were used to elucidate the potential mechanisms. Ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) was applied to identify chemical constituents of XSD. A cobalt (II) chloride (CoCl<sub>2</sub>)-induced hypoxia-mimicking ESC model and an AM mouse model were established to experimentally validate the anti-angiogenic effects of XSD.</p><p><strong>Results: </strong>According to bioinformatics analysis, hypoxia signaling and angiogenesis are crucial for AM progression. Twenty chemical constituents of the 106 compounds identified from the Traditional Chinese Medicine systems pharmacology database and analysis platform database were validated by UHPLC-MS/MS. Network pharmacology identified protein kinase B alpha, epidermal growth factor receptor, hypoxia inducible factor-1α (HIF-1α), and estrogen receptor 1 (ESR1) as core targets. According to <i>in vitro</i> and <i>in vivo</i> experiments, XSD exhibits anti-angiogenic properties through ESR1/G protein-coupled estrogen receptor (GPER)-mediated HIF-1α signaling.</p><p><strong>Conclusion: </strong>Our study confirms that XSD inhibits angiogenesis in AM <i>via</i>ESR1/GPER-mediated HIF-1α signaling. These findings elucidate the molecular mechanisms underlying XSD's therapeutic effects for abnormal uterine bleeding associated with adenomyosis, offering new therapeutic strategies for this condition.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"46 5","pages":"1218-1229"},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684376/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149303491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Jiangtang Xiaozhi formula alleviates type 2 diabetes mellitus by improving islet beta-cell dedifferentiation: a network pharmacology-based study. 降糖消脂方通过改善胰岛β细胞去分化缓解2型糖尿病的网络药理学研究。
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan Pub Date : 2026-10-01 DOI: 10.19852/j.cnki.jtcm.2026.05.014
Zhu Meilin, D U Jianpeng, Luo Yunpeng, Liu Yunlu, Niu Zenghui, Lan Tian, Yang Jing, Chen Zhuhong
{"title":"Jiangtang Xiaozhi formula alleviates type 2 diabetes mellitus by improving islet beta-cell dedifferentiation: a network pharmacology-based study.","authors":"Zhu Meilin, D U Jianpeng, Luo Yunpeng, Liu Yunlu, Niu Zenghui, Lan Tian, Yang Jing, Chen Zhuhong","doi":"10.19852/j.cnki.jtcm.2026.05.014","DOIUrl":"https://doi.org/10.19852/j.cnki.jtcm.2026.05.014","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the underlying therapeutic mechanisms of Jiangtang Xiaozhi formula (JTXZF, )) in the treatment of type 2 diabetes mellitus (T2DM).</p><p><strong>Methods: </strong>The effects of JTXZF on T2DM were evaluated using a db/db mouse model. Potential targets of JTXZF in ameliorating T2DM-related pancreatic beta-cell dedifferentiation were initially predicted using network pharmacology. A beta-cell dedifferentiation model was established in Min6 cells <i>via</i>palmitic acid (PA) intervention. The impact of JTXZF on beta-cell dedifferentiation was assessed through Western blot (WB), immunofluorescence staining, real-time quantitative polymerase chain reaction (RT-qPCR), and siRNA transfection, focusing on the modulation of the phosphatidylinositol 3-kinase/protein kinase B/forkhead box O1 (PI3K/AKT/FoxO1) signalling pathway <i>via</i>insulin-like growth factor 1 (IGF-1). Transmission electron microscopy was employed to examine changes in mitochondrial morphology in Min6 cells, and mitochondrial dysfunction was evaluated using WB and RT-qPCR to assess the intervention effect of JTXZF on beta-cell dedifferentiation.</p><p><strong>Results: </strong>JTXZF improved insulin sensitivity and lipid metabolism, enhanced IGF-1 expression regulating the PI3K/AKT/FoxO1 signalling pathway, upregulated the beta-cell marker transcription factor pancreatic and duodenal homeobox 1, and downregulated the progenitor cell marker neurogenin-3 as well as the pluripotency transcription factor octamer-binding transcription factor 4, thereby inhibiting PA-induced beta-cell dedifferentiation. Additionally, JTXZF appeared to improve beta-cell dedifferentiation mechanisms, possibly by increasing mitofusin 2(Mfn2) expression to alleviate mitochondrial dysfunction.</p><p><strong>Conclusion: </strong>JTXZF modulates the PI3K/AKT/FoxO1 signalling pathway <i>via</i>IGF-1, thereby improving islet beta-cell dedifferentiation in T2DM, and may also regulate Mfn2 expression to mitigate mitochondrial dysfunction.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"46 5","pages":"1206-1217"},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684387/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149303509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bushen Huoxue decoction attenuates osteoporosis in ovariectomized rats through suppressing osteoclast differentiation by targeting sirtuin 1 to deactivate nuclear factor-κB. 补肾活血汤通过靶向sirtuin 1使核因子-κB失活,抑制破骨细胞分化,减轻去卵巢大鼠骨质疏松症。
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan Pub Date : 2026-10-01 DOI: 10.19852/j.cnki.jtcm.2026.05.007
Chen Shuai, Jin Jie, H U Yuwen, Tian Ningsheng, Han Huawei, X U Ziqing, W U Lan, L I Zhiwei
{"title":"Bushen Huoxue decoction attenuates osteoporosis in ovariectomized rats through suppressing osteoclast differentiation by targeting sirtuin 1 to deactivate nuclear factor-κB.","authors":"Chen Shuai, Jin Jie, H U Yuwen, Tian Ningsheng, Han Huawei, X U Ziqing, W U Lan, L I Zhiwei","doi":"10.19852/j.cnki.jtcm.2026.05.007","DOIUrl":"https://doi.org/10.19852/j.cnki.jtcm.2026.05.007","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the anti-osteoporotic effects of Bushen Huoxue decoction (, BSHXD) and its underlying molecular mechanisms in a postmenopausal osteoporosis (PMOP) model.</p><p><strong>Methods: </strong>The model of PMOP was established by bilateral ovariectomy in female rats, and each group were given different doses of BSHXD, or Alendronate by oral gavage. Then, the therapeutic effect of BSHXD on PMOP was estimated using micro-CT analysis, histological staining, and immunohistochemical analysis. <i>In vitro</i> experiment, immunofluorescence analysis, luciferase assay, and co-immunoprecipitation (Co-IP) were used to examine the potential impact and mechanism of BSHXD on osteoclast differentiation. Additionally, Sirtinol was employed to silence Sirt1 and further investigate its involvement in the protective effects of BSHXD.</p><p><strong>Results: </strong>Our study demonstrated that BSHXD ameliorates bone loss and improves trabecular microstructure in osteoporosis model rats. Simultaneously, histological analysis revealed that BSHXD treatment led to a downregulation of tartrate-resistant acid phosphatase (Trap), matrix metalloproteinase 9, and nuclear factor of activated T cells cytoplasmic 1 expression. In addition, the <i>in vitro</i> experiment provided evidence that BSHXD effectively inhibits the formation of osteoclasts and reduces Trap positive osteoclasts. Luciferase assay and CO-IP analysis revealed that BSHXD decreases the acetylation level of nuclear factor NF-kappa-B p65 subunit (p65) and suppresses the activity of nuclear factor-κB (NF-κB), and significantly promotes the binding of Sirtuin 1 (Sirt1) to p65. Notably, after administration with the Sirt1 inhibitor, the antiosteoporotic effect of BSHXD was reduced and NF-κB activity was increased.</p><p><strong>Conclusion: </strong>BSHXD promoted p65 deacetylation by activating Sirt1, thereby inhibiting the NF-κB pathway and subsequently alleviating osteoclast differentiation and bone resorption.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"46 5","pages":"1127-1138"},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684367/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149303363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Xuefu Zhuyu capsule modulates angiogenesis in association with the Jagged1/Notch pathway in lung cancer and chemotherapy contexts. 血府助瘀胶囊在肺癌和化疗背景下通过Jagged1/Notch通路调节血管生成。
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan Pub Date : 2026-10-01 DOI: 10.19852/j.cnki.jtcm.2026.05.005
Wang Yizheng, Zhang Jiayu, L I Yuxia, F U Juanli, Ping Chunjia, L I Yuxuan, Wang He, Gao Dong, Lin Fan
{"title":"Xuefu Zhuyu capsule modulates angiogenesis in association with the Jagged1/Notch pathway in lung cancer and chemotherapy contexts.","authors":"Wang Yizheng, Zhang Jiayu, L I Yuxia, F U Juanli, Ping Chunjia, L I Yuxuan, Wang He, Gao Dong, Lin Fan","doi":"10.19852/j.cnki.jtcm.2026.05.005","DOIUrl":"https://doi.org/10.19852/j.cnki.jtcm.2026.05.005","url":null,"abstract":"<p><strong>Objective: </strong>To elucidate the regulatory effect of Xuefu Zhuyu capsule (, XFZYC) on angiogenesis in the contexts of lung cancer and chemotherapy, and to investigate its correlation with the Jagged1/Notch signaling pathway.</p><p><strong>Methods: </strong>A Lewis lung carcinoma (LLC) tumor-bearing mouse model was established and treated with XFZYC and cisplatin (DDP) for two weeks. Tumor growth was monitored, immunohistochemistry was employed to assess microvessel density in tumor tissues, laser speckle contrast imaging was used to evaluate tumor blood perfusion, and Western blotting was performed to examine the expression of Jagged1/Notch signaling pathway-related proteins. <i>In vitro</i>, a co-culture system of LLC cells and vascular endothelial cells (C166) was used to quantify angiogenesis-related factors in the supernatant after XFZYC drug-containing serum (XFZY-CS) or DDP treatment, followed by tube formation assays to assess C166 angiogenic capacity. Additionally, a stable Jagged1-overexpressing C166 cell line was generated to evaluate drug-mediated regulation of tube formation under chemotherapy conditions.</p><p><strong>Results: </strong><i>In vivo</i> results demonstrated that XFZYC combined with DDP significantly suppressed tumor growth in lung cancer-bearing models (<i>P <</i> 0.01). Compared with the model group, the combination therapy group showed significantly reduced microvessel density and blood perfusion (<i>P <</i> 0.05); however, these parameters were significantly higher in the combination group than in the DDP-alone group (<i>P <</i> 0.05). Relative to the model group, the combination treatment inhibited Jagged1 and vascular endothelial growth factor receptor 2 (VEGFR2) protein expression (<i>P <</i> 0.05) while promoting Notch1 activation and Hey1 protein expression (<i>P <</i> 0.05). In contrast, the combination group exhibited significantly elevated Jagged1 and VEGFR2 expression along with increased Notch1 activation products compared to the DDP-alone group (<i>P <</i> 0.05). <i>In vitro</i> findings revealed that XFZY-CS inhibited tube formation of C166 cells (<i>P <</i> 0.05) and reduced secretion of vascular endothelial growth factor A(VEGFA), basic fibroblast growth factor (bFGF), epidermal growth factor (EGF) as well as Jagged1 protein expression in endothelial cells under lung cancer and chemotherapy conditions (<i>P <</i> 0.05). Notably, following Jagged1 overexpression, XFZY-CS failed to modulate the tube formation ability of C166 cells.</p><p><strong>Conclusion: </strong>In lung cancer and chemotherapy settings, XFZYC moderately suppresses tumor angiogenesis, a process that is associated with the Jagged1/Notch signaling pathway.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"46 5","pages":"1106-1116"},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684371/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149303511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Fuyuan Tongluo acupuncture on neurological function and serum chitinase-3-like protein 1, platelet-activating factor and osteopontin in patients with acute cerebral infarction and its prognostic factors. 复元通络针刺对急性脑梗死患者神经功能及血清几丁质酶-3样蛋白1、血小板活化因子、骨桥蛋白的影响及其预后因素
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan Pub Date : 2026-10-01 DOI: 10.19852/j.cnki.jtcm.2026.05.019
X U Xiaoming, M A Xiaoping
{"title":"Effect of Fuyuan Tongluo acupuncture on neurological function and serum chitinase-3-like protein 1, platelet-activating factor and osteopontin in patients with acute cerebral infarction and its prognostic factors.","authors":"X U Xiaoming, M A Xiaoping","doi":"10.19852/j.cnki.jtcm.2026.05.019","DOIUrl":"https://doi.org/10.19852/j.cnki.jtcm.2026.05.019","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To analyze the effect of Fuyuan Tongluo acupuncture on neurological function, serum chitinase-3-like protein 1 (YKL-40), platelet-activating factor (PAF) and osteopontin (OPN) in patients with acute cerebral infarction and its prognostic factors, so as to provide a scientific basis for clinical judgment of disease condition and optimization of treatment plan.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A total of 102 patients with acute cerebral infarction (ACI) who were hospitalized in the Department of Neurology of Hai'an Hospital of Traditional Chinese Medicine between January 2021 and June 2022 and diagnosed by head computed tomography (CT) and/or magnetic resonance imaging (MRI) were selected as the ACI group, and 40 healthy subjects were selected as the healthy control group. According to the treatment methods documented in the medical records, 102 patients with ACI were divided into group A (50 cases, treated with conventional Western Medicine combined with Fuyuan Tongluo acupuncture) and group B (52 cases, treated with conventional Western Medicine). The clinical efficacy, serum levels of YKL-40, PAF, OPN, and carotid intima-media thickness (IMT) were compared, and the correlation between the levels of the above serum indexes and IMT was analyzed. According to the modified Rankin scale score at 90 d after treatment, the combined group was divided into good prognosis group and poor prognosis group. The baseline data, serum YKL-40, PAF and OPN levels were compared between the two groups, the influencing factors of poor prognosis of ACI were explored, and the predictive value of serum YKL-40, PAF and OPN levels for poor short-term prognosis of ACI was evaluated.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The short-term total effective rate of group A was 90.00%, which was significantly higher than that of group B (69.23%) (&lt;i&gt;P &lt;&lt;/i&gt;0.05). After treatment, the National Institutes of Health Stroke Scale (NIHSS) score, Mini-Mental State Examination (MMSE) score and Barthel index of the two groups were significantly higher than those before treatment, and the scores in group A were higher than those in group B (&lt;i&gt;P &lt;&lt;/i&gt;0.05). After treatment, the serum levels of YKL-40, PAF and OPN in the two groups were significantly lower than those before treatment, and those in group A were lower than those in group B (&lt;i&gt;P &lt;&lt;/i&gt;0.05). The levels of serum YKL-40, PAF, OPN and IMT in ACI group were higher than those in healthy control group (&lt;i&gt;P &lt;&lt;/i&gt;0.05). Serum YKL-40 (&lt;i&gt;r&lt;/i&gt; = 0.426, &lt;i&gt;P &lt;&lt;/i&gt;0.001), PAF (&lt;i&gt;r&lt;/i&gt; = 0.588, &lt;i&gt;P &lt;&lt;/i&gt;0.001), and OPN (&lt;i&gt;r&lt;/i&gt; = 0.474, &lt;i&gt;P &lt;&lt;/i&gt;0.001) levels were positively correlated with IMT in ACI patients, as determined by Pearson correlation analysis. In the poor prognosis group, the levels of IMT, the proportion of unstable plaques, and the concentrations of YKL-40, PAF, and OPN were significantly higher than those in the good prognosis group (&lt;i&gt;P &lt;&lt;/i&gt;0.05). Multivariate logistic regression analysis s","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"46 5","pages":"1266-1275"},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684378/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149303389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multi-target therapeutic mechanism of Qianlie Shule granule against chronic prostatitis: network pharmacology-guided experimental validation. 潜烈疏乐颗粒治疗慢性前列腺炎的多靶点机制:网络药理学引导下的实验验证。
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan Pub Date : 2026-10-01 DOI: 10.19852/j.cnki.jtcm.2026.05.015
Liu Shengjing, Feng Qiujian, Elena Colonnello, Andrea Sansone, Susanna Dolci, Wang Chunlin, Wang Fu, Guo Jun, Guo Boda, Emmanuele A Jannini
{"title":"Multi-target therapeutic mechanism of Qianlie Shule granule against chronic prostatitis: network pharmacology-guided experimental validation.","authors":"Liu Shengjing, Feng Qiujian, Elena Colonnello, Andrea Sansone, Susanna Dolci, Wang Chunlin, Wang Fu, Guo Jun, Guo Boda, Emmanuele A Jannini","doi":"10.19852/j.cnki.jtcm.2026.05.015","DOIUrl":"https://doi.org/10.19852/j.cnki.jtcm.2026.05.015","url":null,"abstract":"<p><strong>Objective: </strong>To elucidate the active constituents and multi-target mechanisms underlying the therapeutic effects of Qianlie Shule granules (, QG) against chronic prostatitis (CP).</p><p><strong>Methods: </strong>QG constituents were profiled by ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry. Putative targets were predicted using network pharmacology and enrichment analyses. Male Sprague-Dawley rats were assigned to control, sham, model, and QG-treated groups (low/medium/high doses). Prostatic injury, inflammation, oxidative stress, and apoptosis were assessed by histology, biochemical assays, and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay. Phosphoinositide 3-kinase/protein kinase B/mechanistic target of rapamycin (PI3K/Akt/mTOR) signaling was evaluated by reverse transcription quantitative polymerase chain reaction and Western blot.</p><p><strong>Results: </strong>Fifty-nine compounds in QG were identified, and 92 potential targets of QG for CP were predicted. The results indicated that apoptosis-related genes and the PI3K/Akt/mTOR signaling pathway were identified as major targets of QG against CP. Further, the results <i>in vivo</i> showed that QG effectively alleviated the histological damage in the prostate, decreased the pro-inflammatory cytokines, and increased the antioxidant capacity. QG reduced apoptosis by reducing the expression of Caspase 3 and Caspase 8. QG upregulated the mRNA levels of PI3K, AKT and mTOR and promoted the phosphorylation of PI3K, AKT and mTOR.</p><p><strong>Conclusion: </strong>QG could ameliorate CP in rats by inhibiting inflammation, oxidative stress, and apoptosis. Moreover, QG could upregulate the anti-apoptotic PI3K/ Akt/mTOR pathway in CP rats.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"46 5","pages":"1230-1239"},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684389/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149303473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modified Danggui Sini formula promotes wound healing regulating natural killer cell function: a network pharmacology-based study targeting killer cell lectin like receptor K1. 当归四逆加减方促进伤口愈合调节自然杀伤细胞功能:针对杀伤细胞凝集素样受体K1的网络药理学研究
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan Pub Date : 2026-10-01 DOI: 10.19852/j.cnki.jtcm.2026.05.013
X U Yannan, Tian Yuan, Wang Xionghui, Xie Wei, Zheng Tianxiao, Pei Zhi, Ling Changquan, D U Juan
{"title":"Modified Danggui Sini formula promotes wound healing regulating natural killer cell function: a network pharmacology-based study targeting killer cell lectin like receptor K1.","authors":"X U Yannan, Tian Yuan, Wang Xionghui, Xie Wei, Zheng Tianxiao, Pei Zhi, Ling Changquan, D U Juan","doi":"10.19852/j.cnki.jtcm.2026.05.013","DOIUrl":"https://doi.org/10.19852/j.cnki.jtcm.2026.05.013","url":null,"abstract":"<p><strong>Objective: </strong>To explore the potential mechanism of the modified Danggui Sini formula (, M-DGSNF) in the treatment of freezing cold injury (FCI).</p><p><strong>Methods: </strong>FCI model rats were used to evaluate the effects of M-DGSNF on wound appearance <i>via</i>histopathological analysis. Furthermore, the potential targets of M-DGSNF were identified <i>via</i>ultra-performance liquid chromatography quadrupole-time-flight mass spectrometry (UPLC-Q-TOF/MS) analysis, network pharmacology and RNA sequencing. Frozen mouse skin sections were analysed by Western blotting and immunohistochemistry. Interleukin (IL)-6, interferon-gamma (IFN-γ), IL-4, IL-10 and vascular endothelial growth factor (VEGF) were assessed by enzyme-linked immunosorbent assay. The effects of M-DGSNF on macrophage polarization were monitored <i>in vitro</i>by flow cytometry. Depletion of natural killer (NK) cells <i>in vivo</i> was used to confirm the role of NK cells in the effects of M-DGSNF.</p><p><strong>Results: </strong>M-DGSNF promoted wound healing and ameliorated the inflammatory response to frostbite wounds in rats with FCI. Additionally, the expression of CD31, alpha-smooth muscle actin (α-SMA), and type I collagen, which promote wound healing, increased after M-DGSNF treatment. Furthermore, killer cell lectin-like receptor k1 (KLRK1) and indoleamine 2,3-dioxygenase 1 (IDO1), which are associated with the function of NK cells, were identified by UPLC-high-resolution mass spectro-metry analysis, network pharmacology and RNA-seq. Accordingly, an increase in the release of inflammatory factors such as VEGF, IFN-γ, IL-6, IL-4, and IL-10 was observed in the early stage of FCI, after which the expression of IFN-γ and IL-6 decreased in the late stage of frostbite. Furthermore, M-DGSNF treatment contributed to M2 macrophage polarization both <i>in vivo</i> and <i>in vitro</i>. Depletion of NK cells abolished the effects of M-DGSNF on wound healing, suggesting that NK cells play a key role in the mechanism by which M-DGSNF affects mice with FCI.</p><p><strong>Conclusion: </strong>M-DGSNF may promote wound healing in mouse models of FCI by regulating the function of NK cells through targeting KLRK1.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"46 5","pages":"1194-1205"},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684365/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149303516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of damp-heat impeding syndrome in rheumatoid arthritis: development and validation of a diagnostic scale. 类风湿关节炎湿热阻证的评估:诊断量表的开发和验证。
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan Pub Date : 2026-10-01 DOI: 10.19852/j.cnki.jtcm.2026.05.021
L I Yanting, Sun Ao, Gong Xun, Tang Xiaopo, Liu Weixiang, Xia Congmin, Wang Jian, Song Mengge, Peng Qiuwei, M A Xieli, Zhou Xiaohua, Jiang Quan
{"title":"Assessment of damp-heat impeding syndrome in rheumatoid arthritis: development and validation of a diagnostic scale.","authors":"L I Yanting, Sun Ao, Gong Xun, Tang Xiaopo, Liu Weixiang, Xia Congmin, Wang Jian, Song Mengge, Peng Qiuwei, M A Xieli, Zhou Xiaohua, Jiang Quan","doi":"10.19852/j.cnki.jtcm.2026.05.021","DOIUrl":"https://doi.org/10.19852/j.cnki.jtcm.2026.05.021","url":null,"abstract":"<p><strong>Objective: </strong>To develop a novel quantitative scale for Damp-Heat Impeding Syndrome (DHIS) in rheumatoid arthritis (RA) and to enhance diagnostic reliability through a combined consensus- and data-driven approach grounded in Traditional Chinese Medicine (TCM) principles, thereby addressing the limitations of existing expert-consensus-based tools.</p><p><strong>Methods: </strong>Scale items were selected from the China Rheumatoid Arthritis Registry of Patients with Chinese Medicine (CERTAIN) database, a prospective, multicenter, observational disease registry for RA patients receiving TCM treatment, and refined through expert consultation. Based on TCM theory and clinical guidance, items were categorized into three domains: disease-related, heat-related, and dampness-related. A two-stage statistical method was applied to estimate item scores and determine cutoff values for each domain. According to TCM diagnostic principles, DHIS is identified only when the scores in all three domains exceed their respective thresholds. To enhance clinical applicability, two versions of the scale were developed: one including pulse manifestations and one excluding them.</p><p><strong>Results: </strong>The dataset was divided based on follow-up time into a development set (<i>n</i> = 6680) and a validation set (<i>n</i> = 3882), both from the CERTAIN database. A DHIS diagnostic scale was developed with two versions: Version 1 included pulse manifestations (11 items), and Version 2 excluded them (10 items). The scale comprised three domains: disease-related, heat-related, and dampness-related. Key symptoms included joint pain as well as tongue and pulse features such as yellow tongue coating and slippery pulse. Secondary symptoms included sticky stool and greasy tongue coating. In the development set, Version 1 achieved a Youden index of 0.83 and sensitivity of 0.89; in the validation set, it achieved 0.78 and 0.86, respectively. Cronbach's α was 0.78 for Version 1 and 0.75 for Version 2.</p><p><strong>Conclusions: </strong>Both versions of the DHIS diagnostic scale demonstrated good internal consistency and strong diagnostic performance, supporting their utility in identifying DHIS among RA patient.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"46 5","pages":"1286-1294"},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684380/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149303394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Jianpi Huayu decoction induces hepatocellular carcinoma apoptosis through flavonoid components targeting tumor protein p53 activation and serine-threonine protein kinase 1/B-cell lymphoma 2 inhibition: a network pharmacology-based study with experimental validation. 健脾化瘀汤通过黄酮类成分靶向肿瘤蛋白p53激活和丝氨酸-苏氨酸蛋白激酶1/ b细胞淋巴瘤2抑制诱导肝癌细胞凋亡:一项基于网络药理学的实验验证研究。
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan Pub Date : 2026-10-01 DOI: 10.19852/j.cnki.jtcm.2026.05.012
Chen Xiaokai, Xie Yingjie, W U Hui, L I Yong, L U Yantong, Tan Wei, Wang Changjun, Huang Xuhui
{"title":"Jianpi Huayu decoction induces hepatocellular carcinoma apoptosis through flavonoid components targeting tumor protein p53 activation and serine-threonine protein kinase 1/B-cell lymphoma 2 inhibition: a network pharmacology-based study with experimental validation.","authors":"Chen Xiaokai, Xie Yingjie, W U Hui, L I Yong, L U Yantong, Tan Wei, Wang Changjun, Huang Xuhui","doi":"10.19852/j.cnki.jtcm.2026.05.012","DOIUrl":"https://doi.org/10.19852/j.cnki.jtcm.2026.05.012","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the bioactive components and molecular mechanisms by which Jianpi Huayu decoction (, JHD) promotes apoptosis in hepatocellular carcinoma (HCC).</p><p><strong>Methods: </strong>A multi-omics strategy integrating serum pharmacochemistry, metabolomics, network analysis, molecular docking, and <i>in vitro</i> validation was employed. Serum-absorbed components were identified from JHD-treated rats. Core targets and pathways were analyzed <i>via</i>protein-protein interaction (PPI) networks and kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment. The effects of key candidate components (apigenin, naringin, daidzein, curzerenone, curcumenol) were validated in human hepatoma G2 cell line cells through cell viability, apoptosis, and protein expression assays.</p><p><strong>Results: </strong>Fifty-one serum-absorbed JHD compounds were identified, comprising eight alkaloids, fifteen flavonoids, nine terpenoids, three quinones, and three phenylpropanoids. Apigenin, naringin, and daidzein demonstrated the highest bioavailability. Network analysis identified tumor protein 53 (TP53), serine-threonine kinase 1 (AKT1), B-cell lymphoma 2 (BCL2), epidermal growth factor receptor (EGFR), and Jun proto-oncogene (JUN) as core targets, which converge on major cancer-related pathways, including phosphatidylinositol 3-kinase (PI3K)-serine-threonine kinase (AKT), mitogen-activated protein kinases (MAPK), and Janus kinase (JAK)-signal transducer and activator of transcription 3 (STAT3). Molecular docking revealed stable binding of naringin to AKT1 [binding energy: -12.6 kcal/mol; root mean square deviation (RMSD): 0.2-0.4 nm]. Apigenin showed the strongest binding affinity for TP53 (-8.2 kcal/mol) and AKT1 (-9.6 kcal/mol). <i>In vitro</i>, apigenin [half maximal inhibitory concentration (IC50) = 48.2 μM at 24 h] significantly upregulated TP53 (<i>P <</i> 0.01) while downregulating BCL2 (<i>P <</i> 0.05), AKT1 (<i>P <</i> 0.01), JUN (<i>P <</i> 0.0001), and EGFR (<i>P <</i> 0.01). Both naringin and curzerenone downregulated AKT1 and BCL2 at 48 h (<i>P <</i> 0.05). In contrast, curcumenol (a structural analog of curzerenone) exhibited no significant regulatory effects (<i>P ></i> 0.05).</p><p><strong>Conclusion: </strong>JHD promotes HCC apoptosis primarily <i>via</i>its flavonoid-enriched components, notably apigenin and naringin, which function by activating TP53 and inhibiting the AKT1/BCL2 signaling axis. This study establishes a \"component-target-pathway\" framework for optimizing herbal formulations and bridges Traditional Chinese Medicine with precision oncology for flavonoid-based HCC therapy.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"46 5","pages":"1180-1193"},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684375/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149303528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书